Does Aurinia's Tang-Led Leadership Overhaul Reshape the Bull Case for Aurinia Pharmaceuticals (AUPH)? [Yahoo! Finance]
Aurinia Pharmaceuticals Inc - Common Shares (AUPH)
Last aurinia pharmaceuticals inc - common shares earnings: 3/5 04:02 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.auriniapharma.com
Company Research
Source: Yahoo! Finance
Hearne as Chief Financial Officer and principal financial officer, and Ryan Cole as Chief Operating Officer, while several prior executives, including former CEO Peter Greenleaf, have exited and Greenleaf now serves briefly as a consultant to support the transition. This shift places Tang Capital–aligned executives in all top operating and financial roles, potentially reshaping how Aurinia prioritizes capital allocation, pipeline development, and operational discipline. We'll now examine how Kevin Tang's move from board chair to CEO may influence Aurinia's existing investment narrative and risk-reward profile. This technology could replace computers: discover 22 stocks that are working to make quantum computing a reality Aurinia Pharmaceuticals Investment Narrative Recap To own Aurinia today, you need to believe LUPKYNIS can support the business while management allocates cash wisely and progresses a still-concentrated pipeline. The Tang Capital led leadership overhaul is si
Show less
Read more
Impact Snapshot
Event Time:
AUPH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AUPH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AUPH alerts
High impacting Aurinia Pharmaceuticals Inc - Common Shares news events
Weekly update
A roundup of the hottest topics
AUPH
News
- Aurinia Pharmaceuticals to Acquire Kezar Life Sciences for $6.955 in Cash per Share Plus a Contingent Value Right [Yahoo! Finance]Yahoo! Finance
- Aurinia Pharmaceuticals to Acquire Kezar Life Sciences for $6.955 in Cash per Share Plus a Contingent Value RightBusiness Wire
- Aurinia Pharmaceuticals: New Management, Continued Lupkynis Performance [Seeking Alpha]Seeking Alpha
- MKT Capital Applauds Aurinia Pharmaceuticals' Management Transition [Yahoo! Finance]Yahoo! Finance
- MKT Capital Applauds Aurinia Pharmaceuticals’ Management TransitionBusiness Wire
AUPH
Earnings
- 2/26/26 - Beat
AUPH
Sec Filings
- 3/25/26 - Form SCHEDULE
- 3/23/26 - Form 8-K
- 3/10/26 - Form 4
- AUPH's page on the SEC website